Replies to post #108859 on Biotech Values

[mcbio]

Why would a partner require MNTA fund 25% of phase 2b trial only? I took MNTA would not start phase 2b trial on its own as that they could fund phase 2b trial on its own if there would be a partner who would fund phase III. Funding a portion of phase III requires huge financial commitment from MNTA.

Rick Shea's co-fund comments were directed specifically towards the next trial for M118, which will be a Phase 2b. As to whether or not MNTA will be required to fund a portion of the Phase 3 trials as well remains to be seen I suppose.